HR
ACGN

Howe & Rusling’s Aceragen Inc ACGN Stock Holding History

Howe & Rusling’s Portfolio ACGN Stock Details ACGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-2
Closed -$1K – 1088
2015
Q3 		$1K Buy
+2
New +$884 ﹤0.01% 972

Other funds holding ACGN

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Howe & Rusling's ACGN Position: Q4 2015 in Review

Howe & Rusling sold out of Aceragen Inc (ACGN) in Q4 2015, closing a stake of 2 shares — an estimated $1K sold.

Howe & Rusling first reported a position in ACGN in Q3 2015 and held it in 1 quarter. The position peaked at $1K in Q3 2015. 86 funds tracked by Wall St. Rank hold ACGN as of Q4 2015.

  • Howe & Rusling reported no remaining Aceragen Inc position as of Q4 2015 after selling out during the quarter.
  • Howe & Rusling sold 2 Aceragen Inc shares in Q4 2015, an estimated $1K.
  • Howe & Rusling first reported a position in Aceragen Inc in Q3 2015 and held it in 1 quarter.
  • Howe & Rusling's Aceragen Inc position peaked at $1K in Q3 2015.
  • 86 funds tracked by Wall St. Rank held Aceragen Inc as of Q4 2015.

Based on Howe & Rusling's 13F filing for Q4 2015, filed 11 Feb 2016.